cholecystokinin (26-33), n-methyl-nle(28,31)- and guanylyl imidodiphosphate

cholecystokinin (26-33), n-methyl-nle(28,31)- has been researched along with guanylyl imidodiphosphate in 1 studies

Compound Research Comparison

Studies (cholecystokinin (26-33), n-methyl-nle(28,31)-)	Trials (cholecystokinin (26-33), n-methyl-nle(28,31)-)	Recent Studies (post-2010) (cholecystokinin (26-33), n-methyl-nle(28,31)-)	Studies (guanylyl imidodiphosphate)	Trials (guanylyl imidodiphosphate)	Recent Studies (post-2010) (guanylyl imidodiphosphate)
8	0	0	2,356	1	18

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bogert, CL; Fang, SN; Hruby, VJ; Knapp, RJ; Vaughn, LK; Yamamura, HI; Yamamura, MS	1

Other Studies

1 other study(ies) available for cholecystokinin (26-33), n-methyl-nle(28,31)- and guanylyl imidodiphosphate

Article	Year
A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): evidence for CCK-B receptor heterogeneity. The Journal of pharmacology and experimental therapeutics, 1990, Volume: 255, Issue:3 Topics: Amino Acid Sequence; Animals; Binding, Competitive; Guanylyl Imidodiphosphate; Humans; Iodine Radioisotopes; Kinetics; Molecular Sequence Data; Peptide Fragments; Rats; Receptors, Cholecystokinin; Sincalide; Succinimides; Swine; Tritium	1990

Article

Year

A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): evidence for CCK-B receptor heterogeneity.

The Journal of pharmacology and experimental therapeutics, 1990, Volume: 255, Issue:3

Topics: Amino Acid Sequence; Animals; Binding, Competitive; Guanylyl Imidodiphosphate; Humans; Iodine Radioisotopes; Kinetics; Molecular Sequence Data; Peptide Fragments; Rats; Receptors, Cholecystokinin; Sincalide; Succinimides; Swine; Tritium

1990